Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: May 14, 2025
Efficacy and Safety of Lumasiran for Advanced Primary Hyperoxaluria Type 1: 24-Month Follow-up of the Phase 3 ILLUMINATE-C Trial.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: March 26, 2024
Hyperuricemia, Elevated Body Mass Index, Female Sex, and Albuminuria Increase the Probability of Elevated High-Sensitivity C-Reactive Protein: Results From the National Health and Nutrition Examination Survey 2015-2018.
Journal: Frontiers in public health
Published: March 31, 2021
Podocytopathy and Nephrotic Syndrome in Mice with Podocyte-Specific Deletion of the Asah1 Gene: Role of Ceramide Accumulation in Glomeruli.
Journal: The American journal of pathology
Published: January 07, 2020
Diagnosis, Treatment, and Outcomes in Children With Congenital Nephrogenic Diabetes Insipidus: A Pediatric Nephrology Research Consortium Study.
Journal: Frontiers in pediatrics
Published: October 16, 2019
Hyperuricemia is associated with a lower glomerular filtration rate in pediatric sickle cell disease patients.
Journal: Pediatric nephrology (Berlin, Germany)
Published: October 14, 2019
Pediatric Nephrology and Rheumatology Practice Patterns in Granulomatosis with Polyangiitis: A Midwest Pediatric Nephrology Consortium Study.
Journal: International journal of nephrology
Published: April 12, 2018
The antenatal urinary tract dilation classification system accurately predicts severity of kidney and urinary tract abnormalities.
Journal: Journal of pediatric urology
Published: January 13, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026